68Ga-labeled DOTA-peptides and 68Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future …

WAP Breeman, E De Blois, HS Chan… - Seminars in nuclear …, 2011 - Elsevier
In this review we give an overview of current knowledge of 68 Ga-labeled pharmaceuticals,
with focus on imaging receptor-mediated processes. A major advantage of a 68 Ge/68 Ga …

Gallium radiopharmaceutical chemistry

MA Green, MJ Welch - International Journal of Radiation Applications and …, 1989 - Elsevier
There are two gallium radioisotopes, 67Ga and 68Ga, possessing nuclear properties”'that
make them attractive for use in nuclear medicine (Table 1). The first, 67Ga, is cyclotron …

The renaissance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry

F Roesch, PJ Riss - Current topics in medicinal chemistry, 2010 - ingentaconnect.com
68Ge/68Ga radionuclide generators have been investigated for almost fifty years now, since
the cyclotronindependent availability of positron emitting 68Ga via the 68Ge/68Ga system …

68Ga-labelled DOTA-derivatised peptide ligands

GJ Meyer, H Mäcke, J Schuhmacher… - European journal of …, 2004 - Springer
Abstract 68 Ge/68 Ga generators provide cyclotron-independent access to positron emission
tomography (PET) radiopharmaceuticals. We describe a system which allows the safe and …

Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical …

M Pagani, S Stone-Elander, SA Larsson - European journal of nuclear …, 1997 - Springer
The increasing amount of clinically relevant information obtained by positron emission
tomography (PET), primarily with fluorine-18 labelled 2-deoxy-2-fluoro-d-glucose, has …

[HTML][HTML] Radionuclide generators: the prospect of availing PET radiotracers to meet current clinical needs and future research demands

A Dash, R Chakravarty - American journal of nuclear medicine and …, 2019 - ncbi.nlm.nih.gov
Targeted molecular imaging with positron emission tomography (PET) constitutes a
successful technique for detecting and diagnosing disease conditions promptly and …

Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides

E de Blois, HS Chan, C Naidoo, D Prince… - Applied Radiation and …, 2011 - Elsevier
OBJECTIVES: PET scintigraphy with 68Ga-labelled analogs is of increasing interest in
Nuclear Medicine and performed all over the world. Here we report the characteristics of the …

Radionuclide generators

F Rösch, FF Knapp - Handbook of nuclear chemistry, 2011 - ui.adsabs.harvard.edu
Radionuclide generator systems continue to play a key role in providing both diagnostic and
therapeutic radionuclides for various applications in nuclear medicine, oncology, and …

Maturation of a key resource–the germanium-68/gallium-68 generator: development and new insights

F Roesch - Current radiopharmaceuticals, 2012 - ingentaconnect.com
68Ge/68Ga radionuclide generators have been investigated for almost fifty years, since the
cyclotronindependent availability of positron emitting 68Ga via the 68Ge/68Ga system had …

Clinical indications for gallium-68 positron emission tomography imaging

MU Khan, S Khan, S El-Refaie, Z Win, D Rubello… - European Journal of …, 2009 - Elsevier
BACKGROUND: 68Ga-PET imaging is showing slow but steady progress when compared to
18F-FDG PET. The advantage of in-house preparation of 68Ga without necessity of a …